D. Boral Capital downgraded Tevogen (TVGN) to Hold from Buy without a price target citing the company’s 50:1 reverse stock split. While the move is largely technical in nature, reverse stock splits are often perceived negatively by the market, and historically, stocks tend to trade lower following such events, the analyst tells investors in a research note. D. Boral believes the split will add additional near-term trading pressure and reflects Tevogen’s weaker capital markets position.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TVGN:
- Tevogen announces 50-for-1 reverse stock split
- Tevogen signs LoI to evaluate acquisition of contract research organization
- Tevogen signs non-binding LOI to evaluate acquisition of Sciometrix
- Tevogen Bio Shareholders Approve Reverse Split Authorization
- Tevogen Bio Explores Potential One-Time Special Cash Dividend
